Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule belonging to the benzoylindole class, structurally related to indomethacin derivatives. It features an indole core substituted with a 4-chlorobenzoyl group, a methoxy group at position 5, and a methyl group at position 2. The acetamide side chain is N-substituted with a (S)-configured hydroxymethylpropyl moiety. The compound has been referenced in chemical databases as an experimental or research molecule but does not have established clinical use or well-documented pharmacological activity in humans. Its mechanism of action is not explicitly described in public sources; however, by analogy to related indomethacin derivatives, it may act as an inhibitor of prostaglandin G/H synthase (cyclooxygenase), though this specific activity for this exact derivative has not been confirmed[6][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1S)-1-(hydroxymethyl)propyl]acetamide.